Contact
Forge Lattice News & Insights About Investors Contact
New field report AI in biomanufacturing keeps stalling. Inside the 2026–2029 outlook on what actually scales. Read the report
Newsroom

Latest from Axio BioPharma.

Announcements, press coverage, and updates from the team building AI-ready biologics manufacturing.

Filter
All AI in Biomanufacturing Forward BIOLABS Wisconsin Biohealth

1 POSTS
Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin
Wisconsin Biohealth Feb 3, 2026 12:00:00 AM

Axio BioPharma Named ICP Round 1 Awardee, Advancing AI-Ready Biologics Manufacturing in Wisconsin

Madison, WI (February 3, 2026) — Axio BioPharma, an AI-ready biologics contract development and manufacturing organization (CDMO), today announced it has been selected as a Round 1 awardee of the Innovation to Commercialization Pipeline (ICP) program, led by Forward BIOLABS in partnership with BioForward Wisconsin.

Read more →